Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MDxHealth SAMDXH · Entity 7018 | Director | June 01, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MDxHealth SA
Report date June 01, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.76 · Expires 2036-05-28 | IndirectBy Ahok BV | 10,000 |
Reported balance
After 2026-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-01 · Grant · Acquired 10,000 · Balance 10,000 F1: Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted. F2: Share Options held by Ahok BV may be deemed to be beneficially owned by the Reporting Person as the owner of 53.33% of Ahok BV. The Reporting Person disclaims beneficial ownership of the securities held by Ahok BV other than to the extent that he may have a pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted.
F2: Share Options held by Ahok BV may be deemed to be beneficially owned by the Reporting Person as the owner of 53.33% of Ahok BV. The Reporting Person disclaims beneficial ownership of the securities held by Ahok BV other than to the extent that he may have a pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2026 Filed Jun 3, 2026 21:30 UTC | MDxHealth SA MDXH · Entity 7018 | GrantShare Option · Derivative | 10,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001193125-26-255805 · ownership.xml · derivative · entry 1 Hoffman Koen · CIK 0002124077 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Ahok BV Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2036-05-28 F1 · derivative.exercise_date: Represents options to purchase 10,000 ordinary shares of the Issuer at a price per share of $0.76 granted on June 1, 2026 which vest in full on the date of the annual general shareholders' meeting that takes place in the calendar year following the calendar year in which the options were granted. F2 · ownership.nature: Share Options held by Ahok BV may be deemed to be beneficially owned by the Reporting Person as the owner of 53.33% of Ahok BV. The Reporting Person disclaims beneficial ownership of the securities held by Ahok BV other than to the extent that he may have a pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.